TABLE 1

Patient Characteristics

Patient no.Age (y)Weight (kg)Injected activity (MBq)Active lesions that have been evaluated
16663562
26850524Subcarinal LN, spinous process bone metastasis, R hilar LN, R T4 transverse process bone metastasis, left lung mass
37560558R femoral head bone metastasis
45156542L peritoneum, gastrohepatic LN, L diaphragm after implantation
569101528
64170554
72857554T spine, upper T spine vertebral body, R L5 bone, L iliac bone metastasis, R iliac bone metastasis
84963562R lung base, L mid lung, L upper lung
954104534L axillary LN
104654548R hilar LN
115263535
125068557Liver metastasis
133261544R breast mass, R axillary LN metastasis
148343502Subcarinal LN, Right hilar LN, L hilar LN
152556505L breast mass
166066560
174882554Peritoneal implant
188575521
194754534
206663557L spine vertebral body, L spine vertebral body, T spine vertebral body
  • LN = lymph node; T = thoracic.